A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects with Phenylketonuria (PKU ASCEND)
|Effective start/end date||4/23/12 → 6/23/13|
- BIOMARIN PHARMACEUTICAL, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.